DocDollars

Global Blood Therapeutics, Inc.

CA · United States · Reporting entity ID 100000771818

Total reported 2019–2025
$25.3M
#277 of 2,960 reporting companies — 0% of all reported industry payments
$6.29M in general payments across 8,719 records, plus $19.0M in research funding across 2,852 records.

How it breaks down

General payments $6,292,520
Research funding $18,958,429

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Global Blood Therapeutics, Inc. reported $25.3M to US doctors and teaching hospitals from 2019 to 2025, ranking #277 of 2,960 reporting companies. 75% of that was research funding and 25% general payments such as consulting, speaking, food and travel. 8,719 general payment records and 2,852 research records were filed.

Common questions about Global Blood Therapeutics, Inc.

How much has Global Blood Therapeutics, Inc. paid US doctors?

Global Blood Therapeutics, Inc. reported $25,250,949 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $6,292,520 in general payments, $18,958,429 in research funding.

How does Global Blood Therapeutics, Inc. rank among drug and device companies?

It ranks #277 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Global Blood Therapeutics, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.